Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2026-01-14 @ 8:51 PM
Study NCT ID:
NCT00410202
Status:
COMPLETED
Last Update Posted:
2013-11-21
First Post:
2006-12-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-03
Start Date Type:
None
Primary Completion Date:
2011-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-11
First Submit QC Date:
None
Study First Post Date:
2006-12-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-04-24
Results First Submit QC Date:
None
Results First Post Date:
2012-07-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-10-29
Last Update Post Date:
2013-11-21
Last Update Post Date Type:
ESTIMATED